scholarly article | Q13442814 |
P356 | DOI | 10.1111/HIV.12432 |
P698 | PubMed publication ID | 27649852 |
P50 | author | Ling Ling Chua | Q87613720 |
P2093 | author name string | J M Roberts | |
A Kamarulzaman | |||
R Rajasuriar | |||
H C Low | |||
I Azwa | |||
H Sulaiman | |||
C Y Leng | |||
M L Chong | |||
Y L Woo | |||
P2860 | cites work | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
Second edition of 'The Bethesda System for reporting cervical cytology' - atlas, website, and Bethesda interobserver reproducibility project | Q24793108 | ||
Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection | Q33449162 | ||
Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay | Q33704883 | ||
Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men. | Q33911805 | ||
Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review | Q34133289 | ||
Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data | Q34210255 | ||
Excess cancers among HIV-infected people in the United States | Q35102629 | ||
A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers. | Q35154570 | ||
Human papillomavirus 16-specific T-cell responses and spontaneous regression of anal high-grade squamous intraepithelial lesions | Q35228283 | ||
Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men | Q35521684 | ||
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy | Q35834104 | ||
Epithelial cell responses to infection with human papillomavirus | Q35940596 | ||
Long-Term Outcomes of Adding HPV Vaccine to the Anal Intraepithelial Neoplasia Treatment Regimen in HIV-Positive Men Who Have Sex With Men. | Q36187651 | ||
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions | Q36189261 | ||
Anal human papillomavirus infection among Thai men who have sex with men with and without HIV infection: prevalence, incidence, and persistence | Q36980208 | ||
Risk of human papillomavirus-associated cancers among persons with AIDS. | Q37309962 | ||
Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions | Q37384414 | ||
Cell-mediated immune responses to human papillomavirus 16 E6 and E7 antigens as measured by interferon gamma enzyme-linked immunospot in women with cleared or persistent human papillomavirus infection | Q37397990 | ||
Global burden of human papillomavirus and related diseases. | Q38064060 | ||
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia | Q39296306 | ||
Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy | Q39530450 | ||
Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trial | Q42239419 | ||
Immunological events in regressing genital warts | Q43760914 | ||
Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. | Q45757921 | ||
Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009. | Q47595604 | ||
Survival of persons with and without HIV infection in Denmark, 1995-2005. | Q50544706 | ||
Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome. | Q51829188 | ||
Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART. | Q51983788 | ||
P433 | issue | 5 | |
P921 | main subject | human papillomavirus 16 | Q69461345 |
P304 | page(s) | 321-331 | |
P577 | publication date | 2016-09-20 | |
P1433 | published in | HIV Medicine | Q15756376 |
P1476 | title | Human papillomavirus 16 (HPV16) and HPV52 E6-specific immunity in HIV-infected adults on combination antiretroviral therapy | |
P478 | volume | 18 |
Q58700642 | Enrichment of gut-derived Fusobacterium is associated with suboptimal immune recovery in HIV-infected individuals | cites work | P2860 |
Search more.